Delphia Therapeutics, Inc.

Cambridge, MA

Massachusetts

Registered In

08/22/2023

Incorp. Date

Foreign

Registration Type

Delaware

Foreign Jurisdiction

Company Summary

Delphia Therapeutics, Inc. at 200 Suite 001, Cambridge, Ma 02139 lists Kevin Marks and Daniel Lynch as associates.

Corporation Service Company Registered Agent	84 STATE ST, BOSTON, MA 02109
Kevin Marks President
Daniel Lynch Director
William Sellers Director
Alexis Borisy Director
Amy Schulman Director
Kevin Marks Director
Kevin Marks Secretary
Kevin Marks TREASURER

200 SUITE 001, CAMBRIDGE, MA 02139 View Map

Form 5500

1 Kendall Square BLDG 200 STE 001, Cambridge, Ma 02139 (401) 497-8766 EIN:88-3526408 Plan Admin:Josh Leibowitz

Year	Plan Name	Participants BOY/EOY	Assets BOY/EOY
2023	Plan NameDELPHIA THERAPEUTICS, INC 401(K) PLAN Plan #001 Participants BOY/EOY2 / 9 Assets BOY/EOY$0 / $146,661	2023	DELPHIA THERAPEUTICS, INC 401(K) PLAN - Plan #001	2 / 9	$0 / $146,661

Benefit & Retirement Plans based on Form 5500.

Address Match:200 Suite 001 Cambridge, MA

Be Biopharma, Inc. Registered in Massachusetts	Cambridge, MA	View Report
Magnet Biomedicine Securities Corporation Registered in Massachusetts	Boston, MA Cambridge, MA	View Report
Myeloid Therapeutics, Inc. Registered in Massachusetts	Cambridge, MA	View Report
Passkey Therapeutics, Inc. Registered in Massachusetts	Cambridge, MA	View Report
Tome Biosciences, Inc. Registered in Massachusetts	Reading, MA Boston, MA (2 more)	View Report
Mitochondria Emotion, Inc. Registered in Massachusetts	Cambridge, MA Boston, MA	View Report

The following government agencies have contributed data:

Secretary of the Commonwealth of Massachusetts U.S. Department of Labor

Manage Profile Opt-Out